Influence of tacrine on dopamine-induced reactions of the gastric smooth muscle of rats.

The clinical usage of the cholinesterase inhibitor tacrine for treatment of Alzheimer's disease is accompanied by adverse effects on the gastrointestinal tract. These adverse effects are a result of the direct action of tacrine on the intestinal smooth muscles or of the modulation of certain neurotransmitters regulating gastrointestinal functions. Dopamine is a neurotransmitter that modulates gastrointestinal motility. This study was designed to examine in vitro the effects of tacrine on dopamine-induced changes in spontaneous activity of smooth muscle preparations from rat's gastric corpus. The mechanical activity was isometrically registered. Tacrine 1.10 7 -1.10 5 mol/l caused smooth muscle contraction. which was blocked by atropine 1.10 -6 mol/l. Tacrine 1.10 -4 mol/l provoked a relaxation resistant to atropine. Dopamine and D 2 -receptor antagonists haloperidol and R121 had no effect on tacrine-induced relaxation. Dopamine-induced contraction was concentration-dependent. It was blocked by D 2 -receptor antagonists haloperidol and R121 and by tacrine 1.10 -4 mol/l. In the presence of tacrine 1.10 -7 -10 -5 mol/l or atropine the dopamine-induced contraction was significant. The data obtained suggested that tacrine 1.10 -4 mol/l inhibited the dopamine effect on gastric corpus smooth muscles. The effect was probably not dependent on its anticholinesterase activity or not realized through direct influence on D 2 -dopamine receptors.